From: A proteomic evaluation of urinary changes associated with cardiopulmonary bypass
Variable | Patients (n = 5) |
---|---|
Age (years) | 75 (73–77) |
Male | 3 (60Â %) |
eGFR (mL/min/1.72 m2) | 72.5 (69.2–76.5) |
Baseline creatinine (mg/dL) | 94 (69–97) |
THAKAR Score | 2 (1–2) |
Diabetes mellitus | 1 (20Â %) |
Chronic obstructive pulmonary disease | 1 (20Â %) |
Hospitalized congestive heart failure | 1 (20Â %) |
Previous myocardial infarction | 2 (40Â %) |
Previous CABG | 0 (0Â %) |
Peripheral arterial disease | 1 (20Â %) |
Amputation or peripheral arterial disease bypass | 0 (0Â %) |
Previous cerebrovascular accident | 0 (0Â %) |
Previous transient ischemic attack | 1 (20Â %) |
Type of surgery (isolated CABG) | 3 (60Â %) |
Pump time (min) | 68 (64–95) |
Cross-clamp time (min) | 54 (36–78) |
Operating room duration (min) | 254 (250–305) |
European system for cardiac operation risk evaluation EuroSCORE II | 1.5 % (1.0–2.4 %) |
Intraoperative urine output (mL) | 1180 (800–1350) |